Aravinda Jagadeesha

Dr Aravind's Diabetes Centre
Bengaluru, KA, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Clinical outcomes of a digitally delivered structured lifestyle program in type 2 diabetes: a randomized controlled trial from India.

Clinical outcomes of a digitally delivered structured lifestyle program in type 2 diabetes: a randomized controlled trial from India.

Journal: Frontiers in endocrinology

Published: June 26, 2026

Metabolic Benefits of Saroglitazar 4 mg in Type 2 Diabetes Mellitus With Dyslipidemia: A Retrospective Real-World Observational Cohort Study From India.

Metabolic Benefits of Saroglitazar 4 mg in Type 2 Diabetes Mellitus With Dyslipidemia: A Retrospective Real-World Observational Cohort Study From India.

Journal: Cureus

Published: June 22, 2026

A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study).

A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study).

Journal: The Journal of the Association of Physicians of India

Published: March 12, 2026

Empagliflozin Perception Mapping Survey.

Empagliflozin Perception Mapping Survey.

Journal: Cureus

Published: December 08, 2025

Knowledge of hypertension and understanding of home blood pressure monitoring among hypertensive patients in India: results from the GRAND Study.

Knowledge of hypertension and understanding of home blood pressure monitoring among hypertensive patients in India: results from the GRAND Study.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: November 30, 2025

A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study.

A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study.

Journal: The Lancet regional health. Southeast Asia

Published: September 28, 2025

May Measurement Month 2022: an analysis of blood pressure screening results from India.

May Measurement Month 2022: an analysis of blood pressure screening results from India.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: September 22, 2025

Assessment of the Awareness of Risk Factors and Current Behavior Among Individuals With Type 2 Diabetes Mellitus in India: A Cross-Sectional Study.

Assessment of the Awareness of Risk Factors and Current Behavior Among Individuals With Type 2 Diabetes Mellitus in India: A Cross-Sectional Study.

Journal: Cureus

Published: March 13, 2025

Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.

Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.

Journal: BMC endocrine disorders

Published: February 22, 2025

Prevalence of Hyperuricemia in Indian Population with Hypertension.

Prevalence of Hyperuricemia in Indian Population with Hypertension.

Journal: The Journal of the Association of Physicians of India

Published: May 08, 2024

Showing 1-10 of 10

Last Updated: 09/26/2026